DE60326272D1 - Komponenten des ampk-wegs - Google Patents

Komponenten des ampk-wegs

Info

Publication number
DE60326272D1
DE60326272D1 DE60326272T DE60326272T DE60326272D1 DE 60326272 D1 DE60326272 D1 DE 60326272D1 DE 60326272 T DE60326272 T DE 60326272T DE 60326272 T DE60326272 T DE 60326272T DE 60326272 D1 DE60326272 D1 DE 60326272D1
Authority
DE
Germany
Prior art keywords
ampk
alter
activity
route
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60326272T
Other languages
English (en)
Inventor
Javier Apfeld
Greg O'connor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elixir Pharmaceuticals Inc
Original Assignee
Elixir Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elixir Pharmaceuticals Inc filed Critical Elixir Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60326272D1 publication Critical patent/DE60326272D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Road Signs Or Road Markings (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Saccharide Compounds (AREA)
DE60326272T 2002-12-04 2003-12-04 Komponenten des ampk-wegs Expired - Fee Related DE60326272D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43080402P 2002-12-04 2002-12-04
US48826103P 2003-07-18 2003-07-18
PCT/US2003/038628 WO2004050898A2 (en) 2002-12-04 2003-12-04 Ampk pathway components

Publications (1)

Publication Number Publication Date
DE60326272D1 true DE60326272D1 (de) 2009-04-02

Family

ID=32474596

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60326272T Expired - Fee Related DE60326272D1 (de) 2002-12-04 2003-12-04 Komponenten des ampk-wegs

Country Status (6)

Country Link
EP (1) EP1576180B1 (de)
AT (1) ATE423218T1 (de)
AU (1) AU2003300818A1 (de)
CA (1) CA2508236A1 (de)
DE (1) DE60326272D1 (de)
WO (1) WO2004050898A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007044622A1 (en) 2005-10-07 2007-04-19 Yale University Use of mif and mif pathway agonists
US20090042810A1 (en) * 2007-04-27 2009-02-12 Genexel-Sein, Inc. AMPK Deficient Animals, Screening Methods, And Related Therapeutics And Diagnostics
GB0715284D0 (en) * 2007-08-06 2007-09-12 Medical Res Council Crystal structure of ampk and uses thereof
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
WO2010005303A2 (en) * 2008-07-07 2010-01-14 Publiekrechtelijke Rechtspersoon Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum New indicators of human longevity and biological ageing rate
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
WO2010151880A2 (en) * 2009-06-26 2010-12-29 The Salk Institute For Biological Studies Increasing lifespan by modulating crtc expression or localization, and methods of screening for modulators of same
US8765377B2 (en) 2011-10-13 2014-07-01 Boston Heart Diagnostics Corporation Compositions and methods for treating and preventing coronary heart disease
WO2014180908A1 (en) * 2013-05-08 2014-11-13 Deutsches Krebsforschungszentrum Acip/peptide-based inhibition of cancer cachexia
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
EP3220810A4 (de) 2014-11-17 2018-05-16 Boston Heart Diagnostic Corporation Beurteilung des risikos für herz-kreislauf-erkrankungen
US20220195389A1 (en) * 2019-04-17 2022-06-23 University Of Houston System Methods of improving the longevity of immune cells
CN115261355B (zh) * 2022-09-14 2023-07-28 广东医科大学 AMPKα1琥珀酰化修饰及应用

Also Published As

Publication number Publication date
CA2508236A1 (en) 2004-06-17
EP1576180B1 (de) 2009-02-18
ATE423218T1 (de) 2009-03-15
EP1576180A4 (de) 2006-08-02
AU2003300818A1 (en) 2004-06-23
WO2004050898A3 (en) 2005-11-10
EP1576180A2 (de) 2005-09-21
WO2004050898A2 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
DE60326272D1 (de) Komponenten des ampk-wegs
NL301145I2 (nl) Tirbanibulin
WO2003094965A8 (en) Modulation of neural stem cells with s1p or lpa receptor agonists
SG170813A1 (en) New compounds
BRPI0517015A (pt) compostos e composições como inibidores de atividade de receptor 1 de canabinóide
CR11107A (es) INDOLES SUSTITUIDOS EN LA POSICION 7 INHIBIDORES DE Mcl-1
ATE400319T1 (de) Tetrahydropyridothiophene
ECSP066392A (de)
MX2010002712A (es) Compuestos que modulan calcio intracelular.
NO20084792L (no) Substituerte imidazol-4-karboksamider som kolecystokinin-1-reseptormodulatorer
ATE538084T1 (de) Bicyclische 1,4-retigabin-analoga als kaliumkanalhemmer
DE602007008868D1 (de) Substituierte imidazol-4-carboxamide als cholecystokinin-1-rezeptor-modulatoren
BRPI0513119A (pt) compostos e métodos modulares de receptores intracelulares
DK1565422T3 (da) Vitamin-D-receptor-modulatorer
ATE435856T1 (de) Vitamin-d-rezeptormodulatoren vom phenyl-thiophen-typ
WO2007120815A3 (en) Methods for treating lymphocyte-associated disorders by modulation of siglec activity
DE602004014188D1 (de) Phenylfuranverbindungen als modulatoren des vitamin-d-rezeptors
IL225745A0 (en) Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds are suitable for the treatment of disorders that respond to dopamine 3d receptor regulation
ATE527379T1 (de) Modulation einer hsv-infektion
ATE536549T1 (de) Galnts als modifikatoren des igfr-weges und verwendungsverfahren
WO2008133936A3 (en) Assays for the identification of compounds that modulate bone formation and mineralization
DE602005025737D1 (de) C20orf23 als modifikator des igfr-wegs und verwendungsverfahren
WO2006031930A3 (en) Modulation of xbp-1 activity for treatment of metabolic disorders
DE602004027387D1 (de) Prkcs als modifikatoren des beta catenin pfads und anwendungsverfahren
ATE506614T1 (de) Gfats als modifikatoren des axin-wegs und verwendungsverfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee